These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18390929)

  • 1. Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut.
    Ban K; Kozar RA
    J Leukoc Biol; 2008 Sep; 84(3):595-9. PubMed ID: 18390929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator-activated receptor-γ during intestinal ischemia/reperfusion.
    Peng Z; Ban K; Wawrose RA; Gover AG; Kozar RA
    Shock; 2015 Apr; 43(4):327-33. PubMed ID: 25394240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel.
    Sato N; Moore FA; Kone BC; Zou L; Smith MA; Childs MA; Moore-Olufemi S; Schultz SG; Kozar RA
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G616-23. PubMed ID: 16257923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion.
    Sato N; Moore FA; Smith MA; Zou L; Moore-Olufemi S; Schultz SG; Kozar RA
    J Trauma; 2005 Mar; 58(3):455-61; discussion 461. PubMed ID: 15761336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats.
    Kozar RA; Schultz SG; Bick RJ; Poindexter BJ; DeSoignie R; Moore FA
    Shock; 2004 May; 21(5):433-7. PubMed ID: 15087819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism.
    Ban K; Sprunt JM; Martin S; Yang P; Kozar RA
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G547-54. PubMed ID: 21737777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/reperfusion.
    Sato N; Kozar RA; Zou L; Weatherall JM; Attuwaybi B; Moore-Olufemi SD; Weisbrodt NW; Moore FA
    Shock; 2005 Nov; 24(5):462-9. PubMed ID: 16247333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type of sodium-coupled solute modulates small bowel mucosal injury, transport function, and ATP after ischemia/reperfusion injury in rats.
    Kozar RA; Schultz SG; Hassoun HT; Desoignie R; Weisbrodt NW; Haber MM; Moore FA
    Gastroenterology; 2002 Sep; 123(3):810-6. PubMed ID: 12198707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut.
    Robinson EK; Kelly DP; Mercer DW; Kozar RA
    JPEN J Parenter Enteral Nutr; 2008; 32(4):433-8. PubMed ID: 18596315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of glutamine and ω-3 polyunsaturated fatty acids on intestinal permeability and lung cell apoptosis during intestinal ischemia-reperfusion injury in a rat model].
    He GZ; Dong LG; Cui XY; Chen XF; Zhang R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):484-9. PubMed ID: 22720351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut.
    Ban K; Santora R; Kozar RA
    Mol Cell Biochem; 2011 Jan; 347(1-2):191-9. PubMed ID: 21046201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion.
    Kozar RA; Verner-Cole E; Schultz SG; Sato N; Bick RJ; Desoignie R; Poindexter BJ; Moore FA
    J Trauma; 2004 Dec; 57(6):1150-6. PubMed ID: 15625443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of enteral nutrients transport in intestinal hypoperfused rat model].
    Li N; Huang Q; Niu LY; Zhu WM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):343-7. PubMed ID: 18636356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enteral nutrition supplemented with octanoic acid on lipopolysaccharide-induced intestinal injury: role of peroxisome proliferator-activated receptor γ/STAT-1/myeloid differentiation factor 88 pathway.
    Tang J; Li X; Li W; Cao C
    Nutrition; 2023 Dec; 116():112216. PubMed ID: 37776839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of enteral nutrition and pharmaconutrients in conditions of splanchnic hypoperfusion.
    de Aguilar-Nascimento JE; Dock-Nascimento DB; Bragagnolo R
    Nutrition; 2010 Apr; 26(4):354-8. PubMed ID: 20004079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of pharmaconutrients.
    Santora R; Kozar RA
    J Surg Res; 2010 Jun; 161(2):288-94. PubMed ID: 20080249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
    Cuzzocrea S
    Vascul Pharmacol; 2004 Jul; 41(6):187-95. PubMed ID: 15653094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut.
    Peng Z; Ban K; Sen A; Grill R; Park P; Costantini TW; Kozar R
    Shock; 2012 Jul; 38(1):57-62. PubMed ID: 22706022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of different enteral nutrients on gut absorptive capacity and energy metabolism during gut ischemia/reperfusion].
    Hu S; Sheng Z; Liu Q; Shi D; Jiang X; Sun D; Zhang R
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):689-91. PubMed ID: 12133468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial].
    Huang XX; Wang XP; Ma JJ; Jing DD; Wang PW; Wu K
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2407-9. PubMed ID: 19087716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.